Skip to main content

Vasodilatantien bei Herzinsuffizienz — Spezielle Indikationen

  • Conference paper

Zusammenfassung

Auf dem Boden unserer Kenntnisse über Vasodilatantien und deren unterschiedliche Wirkungen auf das arterielle und venöse Gefäßsystem ergeben sich einige differentialtherapeutische Gesichtspunkte, die im folgenden abgehandelt werden sollen.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bussmann WD, Walachowa J, Kaltenbach N (1975) Wirkung von Nitroglyzerin beim akuten Myokardinfarkt. 1. Nitroglyzerin sublingual zur Behandlung der Linksherzinsuffizienz und des Lungenödems. Dtsch Med Wochenschr 100:749.

    Article  PubMed  CAS  Google Scholar 

  2. Bussmann WD, Löhner J, Kaltenbach M (1977) Orally administered isosorbiadinitrate in patients with and without left ventricular failure due to myocardial infarction. Am J Cardiol 39:91.

    Article  PubMed  CAS  Google Scholar 

  3. Bolte HD (1977) Therapie bei kardiogenem Schock-Syndrom. Med Welt 28:1710.

    PubMed  CAS  Google Scholar 

  4. Cyran J, Hellwig H, Bolte HD, Karabensch FJ (1978) Einfluß von Nitroglyzerin auf die myokardiale Pumpfunktion bei Linksherzinsuffizienz. Herz/Kreisl 10:116.

    Google Scholar 

  5. Klein G, Wirtzfeld A, Himmler FC, Vogler E (1979) Therapie dekompensierter Herzklappenvitien mit Nitroglyzerin. Dtsch Med Wochenschr 104:582.

    Article  PubMed  CAS  Google Scholar 

  6. Goldberg S, Mann W, Grossmann W (1978) Nitrate therapy of heart failure in valvular heart disease. Am J Med 65:161.

    Article  PubMed  CAS  Google Scholar 

  7. Johnson JB, Gross JF, Hole E (1957) Effects of sublingual nitroglycerin on pulmonary artery pressure in patients with failure of the left ventricle. N Engl J Med 257:1114.

    Article  PubMed  CAS  Google Scholar 

  8. Franciosa JB, Guiha NM, Limas CJ, Cohn JN (1972) Improved left ventricular function during nitroprusside infusion in acute myocardial infarction. Lancet I:650.

    Article  Google Scholar 

  9. Chatterjee K, Parmley WW, Ganz W, Forrester J, Swan HJC (1973) Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation 48:1183.

    PubMed  CAS  Google Scholar 

  10. Chatterjee K, Parmley WW, Swan HJC (1973) Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus. Circulation 48:684.

    PubMed  CAS  Google Scholar 

  11. Miller RR, Vismara LA, De Maria AN, Salel AF, Williams DO, Mason DT (1976) Afterload reduction therapy by nitroprusside in severe aortic regurgitation: Improved cardiac performance and reduced regurgitant volume. Am J Cardiol 38:564.

    Article  PubMed  CAS  Google Scholar 

  12. Capone R, Mason DT, Amsterdam EA, Zelis R (1972) A comparison of the action of short and long-action nitrites on the peripheral circulation. Clin Res 20:204.

    Google Scholar 

  13. Rossen RM, Alderman E, Harrison DC (1976) Circulatory response to vasodilator therapy in congestive cardiomyopathy. Br Heart J 38:695.

    Article  PubMed  CAS  Google Scholar 

  14. Williams DO, Bommer WJ, Miller RR, Amsterdam EA, Mason DT (1977) Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure prolonged effectiveness of isosorbide dinitrate. Am J Cardiol 39:84.

    Article  PubMed  CAS  Google Scholar 

  15. Miller RR, Awan NA, De Maria AN, Mason DT (1977) Importance of maintaining systolic blood pressure during nitroglycerin administration for reducing ischemic injury in patients with coronary disease. Am J Cardiol 40:504.

    Article  PubMed  CAS  Google Scholar 

  16. Gold KH, Leinbach RC, Sanders CA (1972) Use of sublingual Nitroglycerin in congestive failure following acute myocardial infarction. Circulation 46:839.

    PubMed  CAS  Google Scholar 

  17. Chatterjee K, Parmley WW, Massie B, Greenberg B, Werner J, Klausner S, Norman A (1976) Oral hydralazine therapy of chronic refractory heart failure. Circulation 54:880.

    Google Scholar 

  18. Massie B, Chatterjee K, Werner J, Greenberg B, Hart R, Parmley WW (1977) Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. Am J Cardiol 40:794.

    Article  PubMed  CAS  Google Scholar 

  19. Fitchett DH, Neto JAM, Oakley CM, Goodwin JF (1979) Hydralazine in the management of left ventricular failure. Am Cardiol 44:303.

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Bolte, HD. (1981). Vasodilatantien bei Herzinsuffizienz — Spezielle Indikationen. In: Bolte, HD. (eds) Katecholamine und Vasodilatantien bei Herzinsuffizienz. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68257-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-68257-5_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-11025-5

  • Online ISBN: 978-3-642-68257-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics